Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
about
PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectivesAntibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging.uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR).
P2860
Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Urokinase-Type Plasminogen Act ...... PET Biomarker in Glioblastoma.
@en
Urokinase-Type Plasminogen Act ...... PET Biomarker in Glioblastoma.
@nl
type
label
Urokinase-Type Plasminogen Act ...... PET Biomarker in Glioblastoma.
@en
Urokinase-Type Plasminogen Act ...... PET Biomarker in Glioblastoma.
@nl
prefLabel
Urokinase-Type Plasminogen Act ...... PET Biomarker in Glioblastoma.
@en
Urokinase-Type Plasminogen Act ...... PET Biomarker in Glioblastoma.
@nl
P2093
P50
P1476
Urokinase-Type Plasminogen Act ...... PET Biomarker in Glioblastoma.
@en
P2093
Dorthe Skovgaard
Hans S Poulsen
Jacob Madsen
Jesper T Jørgensen
Malene Brandt-Larsen
Mette K Nedergaard
Morten Persson
P304
P356
10.2967/JNUMED.115.161703
P407
P577
2015-10-01T00:00:00Z